...
首页> 外文期刊>Toxicology in vitro: an international journal published in association with BIBRA >Refinement of the Episkin protocol for the assessment of acute skin irritation of chemicals: follow-up to the ECVAM prevalidation study.
【24h】

Refinement of the Episkin protocol for the assessment of acute skin irritation of chemicals: follow-up to the ECVAM prevalidation study.

机译:完善Episkin协议以评估化学物质对皮肤的急性刺激:ECVAM预验证研究的后续行动。

获取原文
获取原文并翻译 | 示例
           

摘要

The Episkin model took part in the prevalidation study on in vitro tests for acute skin irritation of chemicals, which was carried out during 1999 and 2000. This prevalidation study was co-ordinated and supported by the European Centre for the Validation of Alternative Methods (ECVAM). During Phase 1 and Phase 2 of this study, reproducibility and transferability of the method were verified. Unfortunately, the performance of the method in terms of predictive ability was considered insufficient, due to a low specificity. In order to improve the performance of the Episkin method, the existing protocol was refined. This refinement consisted in reducing the exposure time of epidermis with chemicals. Sensitivity, specificity and accuracy of the new method were 70, 80 and 75%, respectively, thus meeting the acceptance criteria as defined by the Management Team. The Episkin method is now ready to enter a validation study of in vitro tests for acute skin irritation.
机译:Episkin模型参与了在1999年和2000年进行的化学药品对皮肤的急性刺激的体外试验的预验证研究。该预验证研究由欧洲替代方法验证中心(ECVAM)协调和支持)。在本研究的第1阶段和第2阶段,验证了该方法的重现性和可转移性。不幸的是,由于特异性低,该方法在预测能力方面的性能不足。为了提高Episkin方法的性能,对现有协议进行了改进。这种改进包括减少表皮与化学物质的接触时间。新方法的敏感性,特异性和准确性分别为70%,80%和75%,从而符合管理团队定义的接受标准。 Episkin方法现已准备好进入急性皮肤刺激的体外测试的验证研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号